We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2881:TWSEFubon Financial Holding Co., Ltd. Analysis

Data as of 2026-06-12 - not real-time

HK$12.16

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Wuhan Youji Holdings Ltd. is trading at HK$12.16, perched just below the identified resistance of HK$13 while comfortably above the 20‑day SMA of 10.36 and the 50‑day SMA of 8.81, suggesting a short‑term bullish bias. However, the RSI of 78 signals an overbought condition and the 30‑day volatility of 62% indicates a highly erratic price environment. Technical momentum remains supportive, with a bullish MACD histogram (+0.09) and a bullish trend direction, yet volume is on a decreasing trajectory, hinting at waning buying pressure. Fundamentally, the company faces steep challenges: revenue has contracted by 25.5%, gross margins sit at a modest 12%, and free cash flow is deeply negative at -HK$217.4 m. The balance sheet is strained, reflected by a debt‑to‑equity ratio of 197% and a payout ratio of 71% against a dividend yield of 3.17%, raising doubts about dividend sustainability. In this context, the stock appears overvalued relative to its earnings (PE ≈ 15.6) and growth prospects, positioning it more as a value play with significant downside risk despite the short‑term technical upside.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Technical bullishness (price above SMA20/50/200, bullish MACD)
  • Overbought RSI and approaching resistance level
  • Decreasing trading volume indicating weakening momentum

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Significant revenue decline and thin profit margins
  • High debt load and negative free cash flow
  • Dividend payout may become unsustainable

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Attractive dividend yield if cash flow improves
  • Fundamental exposure to basic‑materials demand
  • Potential for balance‑sheet restructuring and turnaround

Key Metrics & Analysis

Financial Health

Revenue Growth-25.50%
Profit Margin2.35%
P/E Ratio15.6
ROE9.16%
ROA1.46%
Debt/Equity197.18
P/B Ratio1.4
Op. Cash FlowHK$41.7M
Free Cash FlowHK$-217350752

Technical Analysis

TrendBullish
RSI78.0
SupportHK$9.60
ResistanceHK$13.00
MA 20HK$10.36
MA 50HK$8.81
MA 200HK$6.39
MACDBullish
VolumeDecreasing
Fear & Greed Index86.71

Valuation

GradeOvervalued
TypeValue
Dividend Yield3.17%

Risk Assessment

Beta-0.02
Volatility61.92%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.